scieee Open visual document viewer

Thermoresistant Newcastle disease vaccine effectivelyprotects SPF, native, and commercial chickens inchallenge with virulent virus

Abdoshah, Mohammad; Hassanzadeh, Mohammad; Masoudi, Shahin; Ashtari, Abbas; Yousefi, Alireza; Partovi Nasr, Minoo

Abstract

Background: Due to the more stability and a better homogenecity in immune response, the use of thermoresistant vaccines in different chicken types has been increased. Objective: This study aimed to evaluate the efficacy of a newly developed Newcastle disease vaccine (ND.TR.IR ) originating from 1-2 strain in specific pathogen-free (SPF) and native and broiler chickens. Methods: Following determination of pathogenicity indices on the candidate seed, three efficacy examinations were conducted. In the first experiment, 120 1-day-old SPF chickens were randomly allocated to six groups and either vaccinated with ND.TR.IR via eye drop at 1, 7, and 21 days of age (V-1, V-7, and V-21), or considered as non-vaccinated control groups (C-1, C-7, and C-21). At 20th post-vaccination day, sera hemag-glutination inhibition (HI) antibody titres against ND virus (NDV) were measured and then the chickens were challenged by virulent NDV (vNDV). In the second and third experiments, the efficacy of ND.TR.IR vaccine was compared to routine vaccination program (B1 and LaSota) in native and broiler chickens that were vaccinated at 10 and 20 days of age, respectively. The HI antibody titres were measured on 10, 20, 30, and 40 days of age, and also challenge efficacy test with vNDV was conducted on 30 days of age. Results: The studied virus, as a vaccinal seed, complied with the pathogenicity indices of avirulent NDV and molecular identity of 1-2 strain. In the efficacy evaluation trials, the vaccinated chickens had higher HI antibody titres against NDV compared with their corresponding control chickens (p < 0.05). Results of the challenge tests indicated 95% and 100% protection against vNDV in native, SPF, and broiler-vaccinated chickens, respectively. Conclusions: The present findings indicated that administration of ND.TR.IR induced appropriate HI antibody titres against NDV in SPF, native, and broiler chickens associated with good protection in efficacy test.

Full text

DOI: 10.1002/ ms3.794 ORIGINAL ARTICLE The mo esis an Newcas le disease accine e ec i ely p o ec s SPF, na i e, and comme cial chickens in challenge wi h i ulen i us Mohammad Abdoshah1Mohammad Hassanzadeh2Shahin Masoudi1 Abbas Ash a i1Ali Reza Youse i1Minoo Pa o i Nas 3 1Ag icul u al Resea ch, Educa ion and Ex ension O ganiza ion (AREEO), Razi Vaccine and Se um Resea ch Ins i u e, Ka aj, I an 2Depa men o Poul y Diseases, Facul y o Ve e ina y Medicine, Uni e si y o Teh an, Teh an, I an 3Depa men o Molecula Diagnosis, Mabna Ve e ina y Lab, Ka aj, I an Co espondence Mohammad Abdoshah, Razi Vaccine and Se um Resea ch Ins i u e, Ag icul u al Resea ch, Educa ion and Ex ension O ganiza ion (AREEO), Ka aj, I an. Email: [email p o ec ed], [email p o ec ed] Funding in o ma ion Razi Vaccine and Se um Resea ch Ins i u e, G an /Awa d Numbe : 12-18-18-036-95017-950501 Abs ac Backg ound: Due o he mo e s abili y and a be e homogeneci y in immune esponse, he use o he mo esis an accines in di e en chicken ypes has been inc eased. Objec i e: This s udy aimed o e alua e he e icacy o a newly de eloped Newcas le disease accine (ND.TR.IR) o igina ing om I-2 s ain in speci ic pa hogen- ee (SPF) and na i e and b oile chickens. Me hods: Following de e mina ion o pa hogenici y indices on he candida e seed, h ee e icacy examina ions we e conduc ed. In he i s expe imen , 120 1-day- old SPF chickens we e andomly alloca ed o six g oups and ei he accina ed wi h ND.TR.IR ia eye d op a 1, 7, and 21 days o age (V1,V 7,andV 21), o conside ed as non- accina ed con ol g oups (C1,C 7,andC 21). A 20 h pos - accina ion day, se a hemag- glu ina ion inhibi ion (HI) an ibody i es agains ND i us (NDV) we e measu ed and hen he chickens we e challenged by i ulen NDV ( NDV). In he second and hi d expe imen s, he e icacy o ND.TR.IR accine was compa ed o ou ine accina ion p og am (B1 and LaSo a) in na i e and b oile chickens ha we e accina ed a 10 and 20 days o age, espec i ely. The HI an ibody i es we e measu ed on 10, 20, 30, and 40 days o age, and also challenge e icacy es wi h NDV was conduc ed on 30 days o age. Resul s: The s udied i us, as a accinal seed, complied wi h he pa hogenici y indices o a i ulen NDV and molecula iden i y o I-2 s ain. In he e icacy e alua ion i- als, he accina ed chickens had highe HI an ibody i es agains NDV compa ed wi h hei co esponding con ol chickens (p<0.05). Resul s o he challenge es s indica ed 95% and 100% p o ec ion agains NDV in na i e, SPF, and b oile - accina ed chick- ens, espec i ely. Conclusions: The p esen indings indica ed ha adminis a ion o ND.TR.IR induced app op ia e HI an ibody i es agains NDV in SPF, na i e, and b oile chickens associ- a ed wi h good p o ec ion in e icacy es . This is an open access a icle unde he e ms o he C ea i e Commons A ibu ion-NonComme cial-NoDe i s License, which pe mi s use and dis ibu ion in any medium, p o ided he o iginal wo k is p ope ly ci ed, he use is non-comme cial and no modi ica ions o adap a ions a e made. © 2022 The Au ho s. Ve e ina y Medicine and Science published by John Wiley & Sons L d. Ve Med Sci. 2022;8:1539–1546. wileyonlinelib a y.com/jou nal/ ms3 1539 1540 ABDOSHAH ET AL. KEYWORDS chicken, e icacy, Newcas le disease, he mo esis an , accine 1INTRODUCTION Newcas le disease (ND), a highly con agious and widesp ead poul y disease, is an unde lying con ibu o o economic loss in comme cial and backya d poul y locks (Lawal e al., 2016). The u al poul y a ms play a pi o al ole in ood chain supply in de eloping coun ies; how- e e , hey ha e o en been a ec ed by in ec ious diseases such as ND, occu ing by a ian pa amyxo i us-1 (Ka enbel e al., 2006; Shahid Yousa zai & Liaqua -Ahmad, 2017). Res ic ion o i ulen ND i uses ( NDV) ci cula ion in he backya d chickens could dec ease he isk o he i us ansmission o comme cial a ms (Adwa & Lukeso a, 2008). Vaccina ion agains ND is he mos easible and p o ec i e p e en ion app oach agains ND ou b eaks since he 1940s (Dias e al., 2001). Because o a ela i ely high cos and equi ing long imes o induce immuni y, as well as he need o be injec ed by ained people, he use o inac i a ed ND accines is limi ed in illage locks. The ou ine li e accines (B1 and LaSo a) a e cheape and easie o adminis a e, which ha e made hem mo e accep able o be adminis a ed in u al condi- ions. Ne e heless, main enance o he cold chain o li e accines is he main conce n o achie e e ec i e ND accina ion in a away a eas (Ahle s e al., 1999; Adwa & Lukeso a, 2008). In de eloping coun ies, complying wi h s anda d s o age and cold chain a e somehow di icul ha esul ed in a conside able educ ion o accine e icacy. App oxima ely, a 2-h imeline o adminis a ion o he dissol ed and p epa ed common ND accines is ega ded as a majo limi a ion on hei adminis a ion in u al locks. Al hough lyophiliza- ion and s abilizing excipien s ha e con e ed ma ginal s abili y on many accines, he lack o accines ha possess adequa e he mos a- bili y is o en a p ima y ba ie o global accina ion e o s (Rex oad e al., 2002). Unde inapp op ia e condi ions o he cold chain, adminis a ion o a he mo esis an ND accine could be he p ima y s a egy (Adwa & Lukeso a, 2008). Se e al he mo esis ance i uses d i en om I-2 o HR-V4 s ains ha e been in oduced o manu ac u e ND li e accines (Adwa & Lukeso a, 2008). I has been shown ha he e icacy o hea - esis an ND accines is kep up o 2 mon hs a 9–29◦C, and 2 weeks a 30–37◦C (Alde s, 2014). In his ega d, p e ious in es iga ions (Fen ie e al., 2014; Hassanzadeh e al., 2020; Nasse e al., 2000; Van Bo en e al., 2008) also showed a high p o ec ion agains NDV in chickens accina ed by I-2. The e a e many illage chickens and o he backya d poul y ha a e also po en ial ese oi s o h ea ening o comme cial a ms o NDV (Hassanzadeh & Bozo gme i Fa d, 2004). In his ega d, he p e- en ion o ND occu ence a illage locks is a c ucial s ep in main e- nance sus ainable ag icul u e and con ol o ND ou b eaks in he poul- y indus y. Mos o he in es iga ions on he mos able ND accines ha e ocused on hei usage in u al locks; howe e , hei e icacy on comme cial chickens is a ely s udied. The e o e, his s udy was aimed o e alua e he e icacy o a de eloping Newcas le disease I-2 accine (ND.TR.IR) agains ND in speci ic pa hogen- ee (SPF) and na i e chick- ens as well as comme cial b oile s. 2MATERIALS AND METHODS 2.1 Molecula iden i ica ion o accinal i us and bioin o ma ics analysis A iplica e molecula analysis o he F gene sequences and hei co - esponding amino acids we e ca ied ou o de e mine he iden i y o he i us. Vi us RNA was ex ac ed using a high pu e i al Nucleic Acid ki (Roche, Ge many) acco ding o he manu ac u e ’s ins uc- ions. The ex ac ed RNA was used o syn hesize cDNA using he Re e Aid RT Re e se T ansc ip ion Ki (The mo Fishe Scien i ic). An 840 bp segmen o he F gene sequence including clea age si e was ampli ied using o wa d, 3′-CATCTTCTACCAGGATCCA-5′,and e e se, 3′-CCAAGAGTTGAGTCTGTGAGTC-5′p ime s (F ozandeh- Moghadam e al., 2009). Polyme ase chain eac ion (PCR) was pe - o med using a 5 µl cDNA aliquo in 50 µ; inal olume, including 10 µl PCR bu e (10X) consis ing o 1.5 mM MgCl2,1µl 10 mM dNTPs, 1 µl o 10 pM o each p ime , 1 µl (2 U) Taq DNA polyme ase, and 31 µl double dis illed wa e . Following ini ial dena u a ion a 94◦C o 4 min, 35 cycles including dena u a ion a 94◦C o 60 s, annealing a 50◦C o 60 s, and ex ension a 72◦C o 8 s we e pe o med using a s anda d he mocycle (Eppendo -Ne hele -Hinz GmbH, 5331). The amplicon was hen elec opho esed in 1% low mel ing poin aga ose and isual- ized unde UV ligh using a ansillumina o (bios ep.de, GmbH). The e- a e , he 840 pb bands we e sliced and pu i ied using a high pu e PCR p oduc pu i ica ion ki (Roche) and sequenced using he PCR p ime s and Com o Read me hod (Bionee Co., Ko ea). The nucleo ide sequences we e edi ed and immed and hen we e ansla ed o F p o ein amino acid sequence o he i us. The amino acid sequences we e hen aligned and compa ed wi h comme cial ac- cinal (B1, LaSo a and i s clone, VG/GA, V4, I-2) and s anda d NDV (Roakin, He s33) s ains using BioEdi V7.0.0 so wa e. A phylogene ic analysis was also ca ied ou o iden i y e olu iona y ela ionships among he s udied i us and some i ulen and accinal NDV s ains using MEGA 6.0 so wa e wi h Neighbou -Joining algo i hm and 1000 Boo s aps (Figu e 1). 2.2 Pa hogenici y indices To measu e pa hogenici y indices, esh in ec i e allan oamnionic luid (AAF) wi h haemagglu ina ion (HA) i e >24was dilu ed in s e ile no - mal saline (W. H. Allan e al., 1978). The in ace eb al pa hogenici y 20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License ABDOSHAH ET AL.1541 FIGURE 1 The phylogene ic analysis o he ND.TR.IR F-gene and some comme cial accines (B1, LaSo a and i s clone, VG/GA, V4, I-2) and s anda d i ulen Newcas le disease i us ( NDV) (Roakin, He s33) s ains da ase s, in e ed using he Neighbou -Joining me hod index (ICPI) was de e mined ia in ace eb al injec ion o 0.05 ml o he dilu ed i us in o each o 10 1-day-old SPF chickens. The chickens we e daily e alua ed o gene al and clinical signs o ND, du ing he nex 8 days and sco ed as ollow: 0 o no mal, 1 o sick, and 2 o dead chickens. The ICPI was calcula ed as he mean sco e/chicken/obse a ion o e he examina ion pe iod. The in a- enous pa hogenici y index (IVPI) was de e mined by in a enous injec ion o 0.1 ml o he dilu ed i us in o 10 6-week-old SPF chickens. Chickens we e daily obse ed o gene al and local clinical signs du ing he nex 10 days and sco ed a each obse a ion. The sco e ze o was ega ded o no mal, 1 o sick, 2 o pa alyzed, and 3 o dead chick- ens. The IVPI was calcula ed as he mean sco e pe bi d pe obse a- ion o e he 10 days (W. H. Allan e al., 1978). Mean emb yo dea h ime (MDT) was de e mined h ough inocula ion o 0.1 ml o eshly dilu ed i us om each dilu ion anged 10−6–10−9in o he allan oic ca i y o i e 9- o 10-days-old emb yona ed SPF chicken eggs a 8:00 AM, and incuba ion a 37◦C. The emaining i us dilu ions we e kep a 4◦C. Simila ly, 0.1 ml o each dilu ion was inocula ed in o ano he i e eggs a 5:00 PM and incuba ed a 37◦C. All he incuba ed eggs we e exam- ined wice each day o eco d imes o any emb yo dea hs du ing he nex 7 days. The minimum le hal dosage was de e mined as he highes i us dilu ion in which all o he inocula ed emb yos died. The MDT was calcula ed as he mean ime in hou s o he minimum le hal dose o kill emb yos (W. H. Allan e al., 1978). 2.3 Se ological and challenge e icacy es s The e icacy o he ND.TR.IR was e alua ed h ough h ee sepa a e expe imen s in SPF, comme cial b oile and backya d chickens. All he challenge es s we e unde aken by in amuscula injec ion o ≥105 LD50 o a NDV (He s33) a biosa e y le el 3 in BioFlex B40 Rigid Body Poul y Isola o (Bell Isola ion Sys ems L d, UK). 2.3.1 E icacy e alua ion in SPF chicken A o al o 120 newly ha ched SPF chickens we e andomly alloca ed o h ee accina ed(V1,V7,andV21)and h eecon ol(C 1,C 7,and C21) g oups (20 chickens/g oup). The accina ed chickens we e inocu- la ed wi h ≤106EID50 o he accinal i us (ND.TR.IR) h ough he eye d op a 1 (V1), 7 (V7), and 21 (V21) days o age. Meanwhile, he con- ols chickens ecei ed dis illed wa e by eye d op. Twen y days a e each accina ion ime, all o he accina ed and non- accina ed chick- ens we e challenged. Blood samples we e aken om he expe imen- al g oups o measu e hemagglu ina ion inhibi ion (HI) an ibody i es agains NDV immedia ely be o e he challenge es . Du ing he nex 10 days, daily mo ali y was eco ded, and he su i ed chickens we e con olled o gene al clinical signs o ND (OIE, 2012). 2.3.2 E icacy e alua ion in na i e chicken A o al o 320 1-day-old na i e chickens we e ea ed du ing 50 days o he expe imen al pe iod. Ma e nally de i ed an ibody (MDA) agains NDV was de e mined on 20 andomly selec ed chickens on 1 and 10 days o age (10 chickens/sampling imes). The sampled chickens we e emo ed om he ial, and he emaining chickens we e an- domly allo ed in o h ee expe imen al g oups (100 chickens/g oup) including B1+LaSo a g oup: inocula ion o comme cial B1 and LaSo a accines, a 10 and 20 days o age, espec i ely; ND.TR.IR g oup: inocu- la ion o ND.TR.IR accine a 10 and 20 days o age and Con ol g oup: no accine adminis a ion. Vaccine inocula ion a 10 and 20 days o age was conduc ed h ough eye d op and d inking wa e , espec i ely. To measu e HI an ibody i es agains NDV, blood samples we e collec ed (10 chickens/g oup) a 20, 30, and 40 days o age. On day 30 o age, 20 chickens pe g oup we e ans e ed o isola o s and challenged. [Co ec ion added on 8 Ap il 2022, a e i s online publica ion: “10 chickens” was co ec ed o “20 chickens” in he p eceding sen ence] Du ing he nex 10 days, daily mo ali y was eco ded, and he su i ed chickens we e checked o gene al clinical signs o ND. 2.3.3 E icacy e alua ion in b oile chicken To e alua e he e icacy o ND.TR.IR in b oile chickens, a o al o 470 1-day-old Ross 308 b oile chickens (20 chickens o de e mining MDA, and 450 expe imen al chickens [n=150 chickens /g oup]) we e ea ed unde s anda d en i onmen al and nu i ional condi ions acco ding o Ross B oile Managemen Handbook. Excep o he numbe o 20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License 1542 ABDOSHAH ET AL. FIGURE 2 Compa ison o he amino acid sequence deduced om he F-gene nucleo ide sequence o ND.TR.IR i us wi h se e al comme cial accinal (B1, LaSo a and i s clone, VG/GA, V4, I-2) i uses and i ulen Newcas le disease i us ( NDV) (Roakin, He s33) s ains da ase s. The ND.TR.IR amino acid sequence is accessible unde AHH29550.1. No e: he mo i s loca ed in he box ep esen ing ND.TR.IR and o he NDVs F-p o ein clea age si e challenged chickens which was 10 pe g oup, all o he p ocedu es we e as same as Sec ion 2.3.2 (OIE, 2012). 2.4 Da a analysis Da a ob ained om se a HI an ibody i es we e s a is ically analyzed using a gene alized linea model (GLM) p ocedu e o SAS, 9.4 (SAS, 2004). Be o e he analysis, he no mal dis ibu ion o he da a was es ed by he Shapi o–Wilk es and UNIVARIATE p ocedu e. Mo al- i y a e, as bina y dis ibu ed da a, was analyzed by GENMOD p oce- du e using a logi odds a io link unc ion. The ma hema ical model was as ollows: Yij =µ+Ti+eij whe e Yij is obse a ions, Tiis a ea men e ec , and eij is esidual andom e o . Resul s we e epo ed as mean ±s anda d e o (SE). Tukey’s es was used o mul iple compa isons, and s a is ical di e ences we e decla ed a p<0.05. 3RESULTS 3.1 Vi us iden i y Phylogene ic analysis was based on usion (F) p o ein gene o ND.TR.IR i us, and some comme cial accines and s anda d NDV s ains a e ep esen ed in Figu e 1. The sequence analysis demons a ed a com- ple e iden i y (100%) be ween ND.TR.IR and I-2 s ain, esul ing in dis- ibu ion a he same clus e . The F gene nucleo ide sequence o he s udied i us is a ailable a NCBI gene bank as ND.TR.IR unde he accession numbe KF805771.1. Amino acid sequence compa ison o he s udied i us wi h some comme cial accinal i us and s anda d NDV s ains is shown in Figu e 2. The s udied i us showed a comple e consis ency wi h I-2 s ain, while i had conside able F-p o ein amino acid sequence di e - ences compa ed o o he NDV s ains. The p o eoly ic clea age si e o ND.TR.IR is cha ac e ized by h ee basic amino acids a he ca boxy e minus o F2 and leucine a he amino e minus o F1 (112R-K-Q- G-R*L117) associa ed wi h he a i ulen NDVs. [Co ec ion added on 8 Ap il 2022, a e i s online publica ion: “ i e basic amino acids” was co ec ed o “ h ee basic amino acids” in he p eceding sen ence] TABLE 1 In i o pa hogenici y indices o ND.TR.IR and speci ica ions o accinal Newcas le disease i us (NDV) s ains Pa hogenici y indices S anda d accep able alue*Resul ICPI <0.5 0.0 IVPI 0.0 0.0 MDT (h) >90 138 Abb e ia ions: ICPI, in ace eb al pa hogenici y index; IVPI, in a enous pa hogenici y index; MDT, mean dea h ime. *Values ep esen ing speci ica ions o accinal NDV s ains. 3.2 Pa hogenici y indices Resul s o con en ional in i o pa hogenici y es s and speci ica ions o accinal NDV s ains a e p esen ed in Table 1. Bo h ICPI and IVPI alues measu ed o ND.TR.IR we e ze o. The mean dea h ime (MDT) was 138 h. 3.3 Se ological and challenge e icacy esul s An ibody i es agains NDV in SPF chickens ha we e inocu- la ed wi h ND.TR.IR a e shown in Figu e 3. Vaccina ion inc eased mean HI an ibody i es in V1, V7, and V21 g oups compa ed o hei co esponding con ol g oups (p<0.05). I is wo h no - ing ha accina ion in elde chickens caused highe an ibody i es han ha o younge s (p<0.05). Resul s o he challenge es showed ha ND.TR.IR adminis a ion caused 100% p o ec ion in he accina ed chickens compa ed o hei co esponding con ol chickens. Mean HI an ibody i es agains NDV in na i e chickens immunized ia B1 and Laso a o ND.TR.IR accines a e ep esen ed in Figu e 4. The B1+LaSo a and ND.TR.IR g oups had no signi ican di e ence du - ing he expe imen al pe iod; howe e , hey had highe HI an ibody i es compa ed o he con ol chickens (p<0.05). The MDA i e was dec eased om i s (7.2 ±0.24) o en h (5.6 ±0.26) days o he expe - imen . The dec easing end in MDAwas con inued in he con ol g oup and eached 2.7 ±0.24, 2.0 ±0.21 and <1 a 20, 30, and 40 days o age, 20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License ABDOSHAH ET AL.1543 FIGURE 3 Hemagglu ina ion inhibi ion (HI) an ibody i es agains Newcas le disease i us in speci ic pa hogen ee chickens accina ed by he I-2 s ain (ND.TR.IR) a di e en ages. No e: Chickens we e accina ed wi h a dose o ND.TR.IR (V1, V7, and V21) o ecei ed dis illed wa e (C1,C 7,andC 21) h ough eye d op a 1, 7, and 21 days o age. An ibody i es we e measu ed 21 days a e each adminis a ion ime. Values wi h di e en supe sc ip s (a and b) indica e a signi ican di e ence (p<0.05). E o ba =s anda d e o o he mean espec i ely. Mean HI an ibody i es in he B1+LaSo a and ND.TR.IR g oups showed a g adually dec easing end be ween 10 and 20 days o age; howe e , ollowing he boos e accina ion a day 20 o age, he an ibody le els emained a a cons an le el ( anged be ween 4.1 ± 0.36 and 4.4 ±0.42). Resul s o he challenge es showed 95% p o ec- ion in B1+LaSo a and ND.TR.IR g oups which was highe han 35% o he con ol g oup (p<0.05; Table 2). Mean HI an ibody i es agains NDV in b oile s inocula ed wi h di e en ND accines a e ep esen ed in Figu e 5. The an ibody le - els we e no di e en be ween B1+LaSo a and ND.TR.IR g oups o e he expe imen al pe iod (p<0.05), bu hey had signi ican ly highe HI an ibody i es compa ed o he con ol chickens (p<0.05). A se e e dec easing end in MDA i es was no ed om i s (5.8 ±0.18) o en h (1.7 ±0.22) days o he expe imen . Howe e , ollowing he i s ND accina ion, he an ibody le els we e inc eased in B1+LaSo a (4.30 ±0.45) and ND.TR.IR (4.90 ±0.27) g oups compa ed o he con- ol chickens on day 20 o age (p<0.05). The ea e , he an ibodies i e o B1+LaSo a and ND.TR.IR g oups showed a ela i ely cons an end and each 4.8 ±0.41 and 4.7 ±0.42 on day 30, and 4.3 ±0.49 and 4.2 ±0.39 on day 40 o age, espec i ely. Resul s o he challenge es in his expe imen showed ull p o ec ion (100%) in bo h B1+LaSo a and ND.TR.IR accina ed chickens, while all he un accina ed challenged chickens (con ol) died (Table 2). 4DISCUSSION The welling o adminis a ion he mo esis an accines, especially in illage condi ion, is inc easing du ing las decades. The I-2 is he main ND s ain used o p oducing he mo esis an ND accines o u al chickens. Howe e , i s po en ial use in eme gency accina ion and no e idence o e e s o i ulence has also made i a candida e ac- cine o con ol ND in comme cial locks (Bisschop e al., 2021). In an a emp o p oduce a he mo esis an ND accine, in his s udy, an I- 2 o igina ed accinal seed was success ully cha ac e ized and i s e i- cacy agains ND was in es iga ed in SPF, na i e, and b oile chickens. Resul s o he p esen s udy e ealed a comple e iden i y be ween genomic sequences o he s udied i us and I-2 s ain showing he po en ial o he s udied i us as a accinal seed. Acco ding o W. H. Allan e al. (1978), an a i ulen NDV complies wi h he IVPI, ICPI, and MDT indices when hei co esponding alues a e ze o, less han 0.5, and longe han 90 h, espec i ely. Consis en wi h he molecula FIGURE 4 E ec o adminis a ion a he mo esis an Newcas le disease (ND) accine (ND.TR.IR) e sus common accina ion p og amme (B1 and LaSo a) on an ibody i e agains ND in na i e chickens. No e: The chickens ecei ed a dose o ND.TR.IR o B1 and LaSo a ND accines a days 10 and 20 o age ia eye d op and d inking wa e , espec i ely. Values wi h di e en supe sc ip s (a and b) wi hin each sampling ime indica e a signi ican di e ence (p<0.05). E o ba =s anda d e o o he mean 20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License 1544 ABDOSHAH ET AL. TABLE 2 P o ec ion le el o speci ic pa hogen- ee (SPF), na i e, and b oile chickens accina ed wi h common accina ion p og am (B1 and LaSo a) o a he mo esis an Newcas le disease (ND) accine (ND.TR.IR) in he challenge wi h i ulen ND i us Expe imen al g oups V1 V7 V21 Con ol (C1,C 7, and C21) SPF1100% (10/10)a100% (10/10)a100% (10/10)a0% (0/10)b,2 Expe imen al g oups – B1+LaSo a ND.TR.IR Con ol B oile 3– 100% (10/10)a100% (10/10)a0% (0/10)b Na i e chicken3–95% (19/20)a95% (19/20)a35% (7/20)b 1Chickens in V1, V7, and V21 g oups we e accina ed wi h a dose o ND.TR.IR o ecei ed dis illed wa e (C1,C 7,andC 21) h ough eye d op a 1, 7, and 21 days o age, espec i ely. 2Resul s o con ol g oups in C1, C7, and C21 we e he same. 3The chickens ecei ed B1 and LaSo a o ND.TR.IR accines a days 10 and 20 o age ia eye d op and d inking wa e , espec i ely. a,bWi hin each ow, alues wi h di e en supe sc ip s a e signi ican ly di e en (p<0.05). FIGURE 5 E ec o adminis a ion a he mo esis an Newcas le disease (ND) accine (ND.TR.IR) e sus common accina ion p og am (B1 and LaSo a) on an ibody i e agains ND in b oile chickens. No e: The chickens ecei ed a dose o ND.TR.IR o B1 and LaSo a ND accines a days 10 and 20 o age ia eye d op and d inking wa e , espec i ely. Values wi h di e en supe sc ip s (a and b) wi hin each sampling ime indica e a signi ican di e ence (p<0.05). E o ba =s anda d e o o he mean iden i ica ion esul s, he ob ained alues o he pa hogenici y indices app o ed ha he ND.TR.IR is a candida e accinal seed. In he p esen s udy, h ee expe imen s we e conduc ed o e alu- a e he e icacy o ND.TR.IR. Acco ding o he OIE (2012), he e icacy e alua ion o a li e ND accine mus be conduc ed on 10 o mo e SPF o o he ully suscep ible chickens, a he minimum ecommended age using he minimum ecommended dose. Meanwhile, o ob ain mo e conclusi e esul s, in he i s expe imen , he e icacy o he ND.TR.IR accine was examined in di e en ages o chickens. Ou esul s showed ha he inocula ion o 1-day-old SPF chickens wi h ND.TR.IR was asso- cia ed wi h se a an ibody i es g ea e han 23, a 21 days pos - accina ion. The highe an ibody i es which we e obse ed in he chickens inocula ed a 7 and 21 days o age is explained by he de el- oped immune sys em in he elde chickens (Ambali e al., 2017;Al- Ga ib e al., 2003). The app op ia e se ological immune esponse in chickens ecei ed ND.TR.IR was suppo ed by he esul o he chal- lenge e icacy es , whe e he accina ed chickens we e ully p o ec ed agains NDV in ec ion. I has been documen ed ha chickens wi h HI an ibody i e s ≥23would be p o ec ed ollowing he challenge e i- cacy es (W. Allan & Gough, 1974; Hossain e al., 2010; Hassanzadeh e al., 2020; Van Bo en e al., 2008). Howe e , he e a e pieces o e i- dence showing ha he chickens wi h lowe i e also may su i e a e he challenge (Mee s & Sp adb ow, 2006). In addi ion o he ci cula ing an ibody, cellula and mucosal immuni y a e also in ol ed in acqui ing a good p o ec ion le el in a challenge wi h he i ulen i us; howe e , because o de e mina ion o ci cula ing an ibody is mo e easible and easie , i is conside ed as he p ima y index o e alua ion p o ec ion agains diseases. In he second expe imen , he e icacy o ND.TR.IR on na i e chickens was e alua ed and compa ed wi h a ou ine accina ion 20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License ABDOSHAH ET AL.1545 p og am. Resul s showed an app op ia e HI an ibody aise and p o- ec ion agains NDV in all o he accina ed chickens. In ag eemen wi h 95% p o ec ion eco ded in his expe imen , Ilonggo e al. (2008) epo ed ha he mos able I-2 ND accine p o ided 100% and 89% p o ec ion agains ND in-housed and unhoused chickens, espec i ely. Mo eo e , in es iga ions on u al locks ha e e ealed ha I-2 o igi- na ed accines we e associa ed wi h app oxima ely 80% co e age and long- e m immuni y (Adwa and Lukeso a, 2008). His o ically, he - mos able ND accines ha e been de eloped a he Queensland Uni- e si y and used in se e al de eloping coun ies o con ol ND in u al locks (Mee s & Sp adb ow, 2006); howe e , due o mo e s abili y in ambien empe a u e and la e al ansmission, he he mos able ND accines a e usually associa ed wi h a lowe a ia ion in an ibody i es and cause be e p o ec ion agains ND (Alde s & Sp adb ow, 2001; Illango e al., 2008; Shahid Mahmood e al., 2014). These ad an ages ha e made he he mos able ND accine as a good op ion o he use in comme cial b oile a ms. Resul s o he hi d expe imen e icacy es showed ha immune esponse de i ed om ND.TR.IR o ou ine ND accines (B1 and LaSo a) was no di e en in he comme cial b oile s. Despi e he negli- gible di e ence in se a an ibody i es, bo h immuniza ion p og ammes we e associa ed wi h ull p o ec ion agains NDV. These indings we e in line wi h he esul s o he second expe imen in na i e chickens. Following accina ion, he immunized chickens acqui e humo al and cellula as well as mucosal immuni y. Howe e , by he in amuscula ou e o challenge, he NDV is bypassed h ough mucosal immuni y ha is one o he i s de ensi e ba ie s agains pa hogens. The e- o e, esis ance o challenge wi h he in amuscula ou e is ega ded as he gold s anda d o e alua ing he e icacy o i al accines (Mee s & Sp adb ow, 2006). I has been widely accep ed ha he d immu- ni y p o ides some p o ec ion o subop imal o un accina ed chick- ens (Hassanzadeh & Bozo gme i Fa d, 2004; Kapczynski e al., 2013) i mo e han 85% o he chickens acqui e HI an ibody i es g ea e han 23a e wo ND accina ions (Van Bo en e al., 2008). The cu - en esul s we e co obo a ed by he p e ious s udies which epo ed ha an ibody i e ≥23is he possible p o ec i e le el in chickens ac- cina ed agains ND (W. Allan & Gough, 1974; Bensink & Sp adb ow, 1999; Wambu a, 2011). Meanwhile, Kapczynski and King (2005)sug- ges ed ha a comme cial b oile housing, only chickens wi h HI i es g ea e han 24su i ed in NDV challenge and 66% o chickens wi h lowe an ibody i es emained as unp o ec ed. Mo e commonly, HI i es ≥25a e ypically sugges ed as a p o ec i e le el (W. H. Allan e al., 1978; Kapczynski e al., 2013). In his s udy, 100%, 80%, and 60% o he ND.TR.IR-inocula ed b oile chickens had HI an ibody i es ≥23,2 4,and2 5on day 30 o age, espec i ely (da a we e no shown). Howe e , he ob ained an ibody i es we e associa ed wi h 100% p o- ec ion agains NDV, unde a con olled examina ion. As he inci- dence o ND in chicken locks usually occu ed a 4–5 weeks o age (Hassanzadeh & Bozo gme i Fa d, 2004), he highe p opo ion o chickens wi h p o ec i e i es would dec ease he mo bidi y and mo - ali y a e in he ea ly ND challenge. I is wo h no ing ha he a e age MDA i e was highe in il- lage chickens compa ed o b oile s. P obably, lowe biosecu i y mea- su es in na i e locks han he s ic condi ions obse ed in b oile b eede s cause mo e expose wi h NDV, esul ing in a highe MDA i e in hei o sp ing. In addi ion, he mo e apid dec easing end in MDA i es o b oile s han ha o na i e chickens is explained by he highe me abolic a e associa ed wi h gene ic selec ion o mo e g ow h a e and weigh gain. In acco dance, Gha aibeh and Mahmoud (2013) epo ed ha a ia ions in he MDA hal -li e may s em om ac- o s ela ed o di e ences in chicken lines and ypes. 5CONCLUSION In his s udy, a ecei ed I-2 o igina ed ND i us success ully complied wi h he equi ed speci ica ions o a accinal seed. Also, adminis a ion o he p oduced ND.TR.IR accine p ope ly aised HI an ibody i es associa ed wi h a high p o ec ion le el agains NDV in SPF, na i e, and b oile chickens. These indings sugges ha no only ND.TR.IR migh be use ul o p e en ND ou b eaks in u al locks bu also i could be ad ised o be adminis a ed in comme cial b oile s a ms. Howe e , u he s udies a e wa an ed. ACKNOWLEDGEMENT The au ho s would like o hank he Razi Vaccine and Se um Resea ch Ins i u e o inancial suppo o his p ojec unde g an numbe 12- 18-18-036-95017-950501. CONFLICT OF INTEREST No po en ial con lic o in e es is epo ed by he au ho s. ETHICS STATEMENT The expe imen was conduc ed unde app o al gi en om Razi Vac- cine and Se um Resea ch Ins i u e (RVSRI) E hics Commi ee, Ka aj, I an. AUTHOR CONTRIBUTIONS Concep ualiza ion, me hodology, supe ision, and p ojec adminis a ion: Mohammad Abdoshah and Mohammad Hassanzadeh. Visualiza ion, in es iga ion, w i ing—o iginal d a , and w i ing— e iew and edi ing: Shahin Masoudi and Abbas Ash a i. Fo mal analysis, isualiza ion, w i ing—o iginal d a , and w i ing— e iew and edi ing: Ali Reza Youse i. Me hodology and w i ing—o iginal d a : Minoo Pa o i Nas . DATA AVAILABILITY STATEMENT The da a ha suppo he indings o his s udy a e a ailable on eques om he co esponding au ho . PEER REVIEW The pee e iew his o y o his a icle is a ailable a h ps://publons. com/publon/10.1002/ ms3.794. ORCID Mohammad Abdoshah h ps://o cid.o g/0000-0001-5768-5686 20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License 1546 ABDOSHAH ET AL. REFERENCES Adwa , T., & Lukeso a, D. (2008). E alua ion o he mos able accines agains Newcas le disease in illage chicken used in opics and sub op- ics. Jou nal o Ag icul u e and Ru al De elopmen in he T opics and Sub op- ics,41(2),74–79. Ahle s, C., Hü ne , K., & P ei e , D. (1999). Compa ison be ween a li e and an inac i a ed accine agains Newcas le disease in illage chickens. A ield s udy in no he n Malawi. T opical Animal Heal h and P oduc ion, 31(3), 167–174. h ps://doi.o g/10.1023/A:1005117613340 Al-Ga ib, S., Gielkens, A., G uys, E., & Kochi, G. (2003). Re iew o Newcas- le disease i us wi h pa icula e e ences o immuni y and accina ion. Wo ld’s Poul y Science Jou nal,59(2), 185–200. h ps://doi.o g/10.1079/ WPS20030011 Alde s, R., & Sp adb ow, P. (2001). In oduc ion o li e he mos able New- cas le disease accines. InR. Alde s &P. Sp adb ow (Eds.), Con olling Newcas le disease in illage chickens. A ield manual ( ol. 44, pp. 37–44). Canbe a. Alde s, R. G. (2014). Making Newcas le disease accines a ailable a il- lage le el. Ve e ina y Reco d,174(20), 502–503. h ps://doi.o g/10.1136/ .g3209 Allan, W., & Gough, R. (1974). A s anda d haemagglu ina ion inhibi ion es o Newcas le disease. (1). A compa ison o mac o and mic o me hods. Ve e ina y Reco d,95(6), 120–123. h ps://doi.o g/10.1136/ .95.6.120 Allan, W. H., Lancas e , J. E., & To h, B. (1978). Newcas le disease ac- cines, hei p oduc ion and use: Food and Ag icul u e O ganiza ion o he Uni ed Na ions. h ps://ag is. ao.o g/ag is-sea ch/sea ch.do? eco dID= XF2015002878 Ambali, H., Nwoha, R., & Abdu, P. (2017). E alua ion o an ibody esponse o Newcas le disease accina ion in chickens in some comme cial a ms- Ii wo local go e nmen a eas in Lagos S a e, Nige ia. Jou nal o Ve - e ina y Medicine and Su ge y,1(2), 1–6. h ps://doi.o g/10.9734/AJEA/ 2016/27456 Bensink, Z., & Sp adb ow, P. (1999). Newcas le disease i us s ain I2—A p ospec i e he mos able accine o use in de eloping coun ies. Ve - e ina y Mic obiology,68(1–2), 131–139. h ps://doi.o g/10.1016/S0378- 1135(99)00069-3 Bisschop, S. P., Pe e s, A., Domingue, G., Pea ce, M. C., Ve wey, J., & Poolman, P. (2021). Newcas le disease accine i us I-2 ails o acqui e i ulence du ing epea ed passage in i o. Ga es Open Resea ch,5, 76. h ps://doi. o g/10.12688/ga esopen es.13212.2 Dias, P., Alde s, R., F inge, R., & Ma a, B. (2001). Labo a o y and ield i- als wi h he mos able li e Newcas le disease accines in Mozambique. P oceedings o an In e na ional Wo kshop.ACIAR P oceedings No. 103, 6–9 Ma ch, 2000, Mapu o, Mozambique. Fen ie, T., Dadi, K., Kassa, T., Sahle, M., & Ca oli, G. (2014). E ec o accina- ion on ansmission cha ac e is ics o highly i ulen Newcas le disease i us in expe imen ally in ec ed chickens. A ian Pa hology,43(5), 420– 426. h ps://doi.o g/10.1080/03079457.2014.951832 F ozandeh-Moghadam, M., Madani, R., Dehghani, M., Mosa i, S., Pou bakhsh, S., & Golchin a , F. (2009). Cloning & exp ession o p o ein gene (HR1 egion) o Newcas le disease i us NR43 iso- la e om I an in E. coli.I anian Jou nal o Vi ology,3(3), 16–22. h ps://doi.o g/10.21859/is .3.3.16 Gha aibeh, S., & Mahmoud, K. (2013). Decay o ma e nal an ibodies in b oile chickens. Poul y Science,92(9), 2333–2336. h ps://doi.o g/10. 3382/ps.2013-03249 Hassanzadeh, M., Abdoshah, M., Youse i, A. R., & Masoudi, S. (2020). Com- pa ison o he impac o di e en adminis a ion ou es on he e icacy o a he mo esis an Newcas le disease accine in chickens. Vi al Immunol- ogy,33(5), 361–366. h ps://doi.o g/10.1089/ im.2019.0125 Hassanzadeh, M., & Bozo gme i Fa d, M. (2004). A se ological s udy o New- cas le disease in p e-and pos - accina ed illage chickens in no h o I an. In e na ional Jou nal o Poul y Science,3(10), 658–661. h ps://doi. o g/10.3923/ijps.2004.658.661 Hossain, K. M. M., Ali, M. Y., & Yama o, I. (2010). An ibody le els agains Newcas le disease i us in chickens in Rajshahi and su ounding dis ic s o Bangladesh. In e na ional Jou nal o Biology,2(2), 102–106. h ps://doi. o g/10.5539/ijb. 2n2p102 Illango, J., Mukiibi-Muka, G., Abila, P., Musisi, G., & E oo i, A. (2008). The alue o he Newcas le disease I-2 he mos able accine use in he u al ee- ange poul y managemen sys em in Uganda. Li es ock Resea ch o Ru al De elopmen ,20(9), 9–13. Kapczynski, D. R., A onso, C. L., & Mille , P. J. (2013). Immune esponses o poul y o Newcas le disease i us. De elopmen al and Compa a i e Immunology,41(3), 447–453. h ps://doi.o g/10.1016/j.dci.2013.04.012 Kapczynski, D. R., & King, D. J. (2005). P o ec ion o chickens agains o e clinical disease and de e mina ion o i al shedding ollowing accina- ion wi h comme cially a ailable Newcas le disease i us accines upon challenge wi h highly i ulen i us om he Cali o nia 2002 exo ic New- cas le disease ou b eak. Vaccine,23(26), 3424–3433. h ps://doi.o g/10. 1016/j. accine.2005.01.140 Ka enbel , J., Mee s, J., & Gould, A. (2006). Genome sequence o he he - mos able Newcas le disease i us (s ain I-2) e eals a possible pheno- ypic locus. Ve e ina y Mic obiology,114(1–2), 134–141. h ps://doi.o g/ 10.1016/j. e mic.2005.10.041 Lawal, J. R., El-Yuguda, A. D., & Ib ahim, U. I. (2016). E icacy o eed coa ed Newcas le disease I2 accine in Village Chickens in Gombe S a e, Nige- ia. Jou nal o Ve e ina y Science and Technology,7, 349. h ps://doi.o g/10. 4172/2157-7579.1000349 Mee s, J., & Sp adb ow, P. (2006). Assessing Newcas le disease accines o use in illage locks. P oceedings o he 11 h In e na ional Symposium on Ve e ina y Epidemiology and Economics, Cai ns, Aus alia. Nasse , M., Loh , J., Meb a u, G., Zessin, K.-H., Baumann, M., & Ademe, Z. (2000). O al Newcas le disease accina ion ials in E hiopia. A ian Pa hology,29(1), 27–34. h ps://doi.o g/10.1080/03079450094243 OIE: Wo ld O ganisa ion o Animal Heal h. (2012). Manual o diagnos ic es s and accines o e es ial animals. Rex oad, J., Wie ho , C. M., Jones, L. S., & Middaugh, C. R. (2002). Lyophiliza- ion and he he mos abili y o accines. Cell P ese a ion Technology, 1(2), 91–104. h ps://doi.o g/10.1089/153834402320882593 S a is ical Analysis Sys em. (2004). SAS Use ’s Guide S a is ics.Ca y,NC:SAS Ins ., Inc. Shahid Mahmood, M., Siddique, F., Hussain, I., Ahmad, S. I., & Ra ique, A. (2014). The mos able accines o Newcas le disease: A e iew. Wo ld’s Poul y Science Jou nal,70(4), 829–838. h ps://doi.o g/10.1017/ S0043933914000889 Shahid Yousa zai, A., & Liaqua -Ahmad, F. (2017). E ec Newcas le disease on poul y due o high mo bidi y and mo ali y a es. Global Jou nal o Poul y Fa ming and Vaccina ion,5(3), 362–367. Van Bo en, M., Bouma, A., Fab i, T. H., Ka sma, E., Ha og, L., & Koch, G. (2008). He d immuni y o Newcas le disease i us in poul y by accina ion. A ian Pa hology,37(1), 1–5. h ps://doi.o g/10.1080/ 03079450701772391 Wambu a, P. N. (2011). Fo mula ion o no el nano-encapsula ed Newcas le disease accine able s o accina ion o illage chickens. T opical Animal Heal h and P oduc ion,43(1), 165–169. h ps://doi.o g/10.1007/s11250- 010-9669-0 How o ci e his a icle: Abdoshah, M., Hassanzadeh, M., Masoudi, S., Ash a i, A., Youse i, A. R., & Pa o i Nas , M. (2022). The mo esis an Newcas le disease accine e ec i ely p o ec s SPF, na i e, and comme cial chickens in challenge wi h i ulen i us. Ve e ina y Medicine and Science,8, 1539–1546. h ps://doi.o g/10.1002/ ms3.794 20531095, 2022, 4, Downloaded om h ps://onlinelib a y.wiley.com/doi/10.1002/ ms3.794 by Technical Uni e si y In B no, Wiley Online Lib a y on [31/07/2023]. See he Te ms and Condi ions (h ps://onlinelib a y.wiley.com/ e ms-and-condi ions) on Wiley Online Lib a y o ules o use; OA a icles a e go e ned by he applicable C ea i e Commons License